Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 14, 2021; 27(22): 3073-3084
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3073
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3073
Figure 4 Enhancer of zeste homolog 2 inactivates janus kinase 2/ signal transducer and activator of transcription signaling in colonic epithelial cells.
A and B: The NCM460 and fetal human colon (FHC) cells were treated with control shRNA or enhancer of zeste homolog 2 (EZH2) short hairpin RNA. Western blot analysis of the Janus kinase 2 (JAK2), Signal transducer and activator of transcription 3 (STAT3), and EZH2 expression and JAK2 and STAT3 phosphorylation; C and D: The NCM460 and FHC cells were treated with GSK343 (5 μM). Western blot analysis of the JAK2, STAT3, and EZH2 expression and JAK2 and STAT3 phosphorylation. n = 3.
- Citation: Zhou J, Yang Y, Wang YL, Zhao Y, Ye WJ, Deng SY, Lang JY, Lu S. Enhancer of zeste homolog 2 contributes to apoptosis by inactivating janus kinase 2/ signal transducer and activator of transcription signaling in inflammatory bowel disease. World J Gastroenterol 2021; 27(22): 3073-3084
- URL: https://www.wjgnet.com/1007-9327/full/v27/i22/3073.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i22.3073